Novartis Pharmaceuticals and Sandoz Products

A B C D E F G J L M N O P R S T U V X Z

Advanced or metastatic bladder cancer with Cisplatin, NSCLC, metastatic adenocardnoma of the pancreas, locally advanced or metastatic epithelial ovarian carcinoma, in combination with Cararboplatin

Gemcitabin Hexal

Gemcitabine
Advanced or metastatic bladder cancer with Cisplatin, NSCLC, metastatic adenocardnoma of the pancreas, locally advanced or metastatic epithelial ovarian carcinoma, in combination with Cararboplatin
Anticancer
Sandoz

Chronic myeloid leukemia (Ph+ CML), Ph+ CML in blast crisis, Lymphoblastic leukemia (Ph+ ALL),MDS/MPD,SM,HES,CEL,CD117,GIST,Kit+ GIST, DFSP Protein-tyrosine kinase inhibitor

Glivec

Imatinib
Chronic myeloid leukemia (Ph+ CML), Ph+ CML in blast crisis, Lymphoblastic leukemia (Ph+ ALL),MDS/MPD,SM,HES,CEL,CD117,GIST,Kit+ GIST, DFSP Protein-tyrosine kinase inhibitor
Novartis Pharmaceuticals

Type 2 diabetes mellitus (T2DM) Diabetes, DPP-4 inhibitors

Galvus

Vildagliptin
Type 2 diabetes mellitus (T2DM) Diabetes, DPP-4 inhibitors
Novartis Pharmaceuticals

Galvus Met

Vildagliptin, Metformin Hydrochloride
Type 2 diabetes mellitus (T2DM) Diabetes, DPP-4 inhibitors
Novartis Pharmaceuticals